TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ROIV

Roivant Sciences Ltd

Healthcare · Biotechnology

39.80$ -0.5% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Roivant Sciences Ltd (ROIV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 5,306 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ROIV
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
2,066 7,313 7,222 6,206 6,206 5,792 5,437 5,033 5,063 5,225 5,728 5,306
1,552 6,807 6,732 5,801 5,801 5,364 5,000 4,616 4,512 4,660 5,167 4,742
1,414 6,671 6,536 1,959 1,959 1,991 2,715 1,238 1,237 1,478 1,423 1,248
1,414 6,671 6,541 5,387 5,387 5,147 4,887 4,503 4,386 4,530 4,296 3,842
55 63 83 23 23 144 790 793
4.9 5.2 35 34 -193
73
141 150 138 136
740 728 774 626 626 256 250 217 257 251 436 385
266 245 267 556 556 141 149 114 134 152 281 284
60 56 22 9.5 9.5 9.8 9.8 9.4 9.0 10 11 12
44 35 53 25 25 24 24 12 15 13 18 25
389 403 431 312
949 6,090 5,969 5,153 5,153 5,189 4,688 4,346 4,362 4,269 4,527 4,231
-4,369 727 576 396 396 460 116 -316 -429 -695 -502 -900
770 844 803 735 735 723 707 680 681 697 812 721

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?